Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs Oxytocin + Syntometrine for PPH Prevention
NCT02046499Phase 4Completed
- Sponsor
- University of Pretoria
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin + ergonovine in postpartum hemorrhage (PPH), sponsored by University of Pretoria. Started Jan 2014; status: completed.
02
Drugs
oxytocin + ergonovine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02046499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046499.